Literature DB >> 28215492

Dietary Intake, Nutritional Status, and Body Composition in Children With End-Stage Kidney Disease on Hemodialysis or Peritoneal Dialysis.

Consuelo Pontón-Vázquez1, Edgar Manuel Vásquez-Garibay2, Erika Fabiola Hurtado-López1, Adriana de la Torre Serrano3, Germán Patiño García3, Enrique Romero-Velarde4.   

Abstract

OBJECTIVE(S): This study aimed to demonstrate that dietary intake, anthropometric indicators, and body composition in children with end-stage kidney disease differs between those on peritoneal dialysis (PD) and those on hemodialysis (HD).
METHODS: This was a cross-sectional and consecutive study that included 55 children and adolescents with end-stage kidney disease who were undergoing replacement therapy (22 PD patients and 33 HD patients). Two 24-hour dietary recall surveys were conducted for each patient. Anthropometric, biochemical, and body composition indicators were estimated. A Student's t-test and a Mann-Whitney U test were used for the parametric variables, whereas association tests were estimated for the nonparametric variables (i.e., χ2, Fisher exact test, and odds ratio). Regression models were designed to predict dietary intake on anthropometric and body composition indicators.
RESULTS: The mid-upper arm circumference was greater on the patients undergoing HD than on the PD patients (odds ratio = 15.8 [95% confidence interval (CI): 2.9, 85.1], P < .001); the arm muscular area was greater in the HD patients than in the PD patients (P = .07). Children on PD had significantly greater creatinine concentration (8.4 ± 3.0 mg/dL vs. 4.6 ± 1.2 mg/dL, P < .001), urea (101 ± 27 mg/dL vs. 50 ± 17 mg/dL, P < .001), and glucose (87 ± 14.4 mg/dL vs. 77 ± 10.2 mg/dL, P = .003). Children on PD had lower lipid intake (31.2 ± 15.8 vs. 40.9 ± 19.1 g/day, P = .032), lower percentage of adequacy of vitamin C (128 ± 66 vs. 146 ± 70, P = .046), and lower sodium (62 ± 43 vs. 79 ± 42, P = .044) than children on HD. Dietary intake predicted 40% to 80% of the variability in the nutritional status in children on PD and 28% to 60% in children on HD.
CONCLUSIONS: Nutritional status is affected in most patients on dialysis treatment, which differs significantly among those who are undergoing PD or HD.
Copyright © 2017 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28215492     DOI: 10.1053/j.jrn.2016.12.007

Source DB:  PubMed          Journal:  J Ren Nutr        ISSN: 1051-2276            Impact factor:   3.655


  4 in total

1.  Body Fat in Children with Chronic Kidney Disease - A Comparative Study of Bio-impedance Analysis with Dual Energy X-ray Absorptiometry.

Authors:  Arpana Iyengar; Rebecca Kuriyan; Anura V Kurpad; Anil Vasudevan
Journal:  Indian J Nephrol       Date:  2020-11-07

Review 2.  Nutritional Status in Peritoneal Dialysis: Nutritional Guidelines, Adequacy and the Management of Malnutrition.

Authors:  Thomas Kiebalo; Jacqueline Holotka; Ireneusz Habura; Krzysztof Pawlaczyk
Journal:  Nutrients       Date:  2020-06-08       Impact factor: 5.717

3.  Symmetric dimethylarginine concentrations in dogs with International Renal Interest Society stage 4 chronic kidney disease undergoing intermittent hemodialysis.

Authors:  André Nanny Vieira Le Sueur; Silvano Salgueiro Geraldes; Alessandra Melchert; Regina Kiomi Takahira; Michael Coyne; Rachel Murphy; Donald Szlosek; Priscylla Tatiana Chalfun Guimarães-Okamoto
Journal:  J Vet Intern Med       Date:  2019-09-12       Impact factor: 3.333

Review 4.  Assessment of nutritional status in children with kidney diseases-clinical practice recommendations from the Pediatric Renal Nutrition Taskforce.

Authors:  Christina L Nelms; Vanessa Shaw; Larry A Greenbaum; Caroline Anderson; An Desloovere; Dieter Haffner; Michiel J S Oosterveld; Fabio Paglialonga; Nonnie Polderman; Leila Qizalbash; Lesley Rees; José Renken-Terhaerdt; Jetta Tuokkola; Johan Vande Walle; Rukshana Shroff; Bradley A Warady
Journal:  Pediatr Nephrol       Date:  2020-12-14       Impact factor: 3.714

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.